SANOFICONRSanofi Consumer Healthcare India Limited
Pharma · Drug Manufacturers - General · NSE · as of 2026-09-11 (delayed ~30 min in market hours)
Sanofi Consumer Healthcare India Limited operates as a fast-moving consumer healthcare company in India. The company offers products in the allergy, physical wellness, and pain care segments under Allegra, Combiflam, Avil, DePURA, Festal, and other brand names through distributors, wholesalers, government institutions and hospitals, pharmacy chains, and e-commerce platforms. The company was incorporated in 2023 and is based in Mumbai, India. Sanofi Consumer Healthcare India Limited operates as a subsidiary of Opella Healthcare Participations B.V.
Price & Volume
Loading chart…
Key Ratios
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
None of the 16 pattern scanners currently detects a setup on SANOFICONR — signals appear here automatically when one forms (checked on every data refresh). The Trade Plan on the right always provides stop-loss and target levels regardless.
The picture
- • Revenue growth: 32.8% YoY
- • Profit growth: 35.7% YoY
- • ROE: 62.5%
- • Sector momentum: sector +6.2% (1m)
- • Volatility: 31% annualized
- • Beta: 0.50
Bull case
- • Revenue growth: 32.8% YoY
- • Profit growth: 35.7% YoY
- • ROE: 62.5%
- • Sector momentum: sector +6.2% (1m)
Bear case
- • RSI: 28
- • MACD: bearish
- • 1-month return: -10.0%
- • 1-month vs NIFTY: -5.9% relative
Key risks
- • Momentum is fading versus the broader market
- • RSI: 28
- • MACD: bearish
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹105.29). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.